TTP Investments’s AbbVie ABBV Stock Holding History

TTP Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,141	Closed	-$508K	–	40
2022 Q4	$508K	Sell	3,141 -62	-2%	-$9.51K	0.53%	21
2022 Q3	$430K	Buy	3,203 +632	+25%	+$90.7K	0.52%	20
2022 Q2	$394K	Buy	2,571 +198	+8%	+$30.3K	0.47%	18
2022 Q1	$385K	Sell	2,373 -28	-1%	-$4.07K	0.39%	17
2021 Q4	$325K	Buy	+2,401	New	+$284K	0.22%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

TTP Investments's ABBV Position: Q1 2023 in Review

TTP Investments sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 3,141 shares — an estimated $508K sold.

TTP Investments first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $508K in Q4 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

TTP Investments reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
TTP Investments sold 3,141 AbbVie shares in Q1 2023, an estimated $508K.
TTP Investments first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
TTP Investments's AbbVie position peaked at $508K in Q4 2022.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on TTP Investments's 13F filing for Q1 2023, filed 4 May 2023.